This antiviral agent is an inhibitor that binds to one of the co-receptors which is found on the surface of macrophages or T cells. and blocks an HIV envelope protein from fusing the viral envelope with the host cell membrane. It is indicated for use in treatment-experienced adult patients infected with a susceptible HIV-1 strain who have evidence of infection by a virus with resistance to multiple anti-HIV agents.

Question

Quizplus · Accepted Answer

Maraviroc works by binding to the CCR5 co-receptor on the surface of T cells and macrophages, blocking the entry of HIV into the host cell. This mechanism is distinct from those of AZT, bictegravir, and darunavir, making maraviroc the correct answer.

This Antiviral Agent Is an Inhibitor That Binds to One